Quanta is committed to the development and careful evaluation of novel therapeutics with the goal to help patients. Currently our therapies are investigational, which means that they have not been approved as safe and effective by the United States Food and Drug Administration (FDA) or other Health Authorities. We believe it is important to provide our investigational therapies to patients who are participating in the setting of one of our clinical trials. Use outside of a clinical trial can potentially compromise the broader development program that is being conducted to carefully evaluate the safety and efficacy of the therapy in support of product registration. However, we recognize that access through a clinical trial is not always possible for every patient and there may be circumstances, particularly later in development, where investigational therapies may be made available to Physicians via Expanded Access.
A listing of our clinical trials can be found on https://clinicaltrials.gov.